The primary tumour showed a low risk factor (diameter < 2 cm, low histological grade, absence of vascular invasion, low proliferation rate assessed by Ki67, Her-2 negative immunostain), with the exception of the hormone receptors, which proved to be negative. The gene discussed is ERBB2; the disease is neoplasm.